EyePoint (EYPT) Stock
EyePoint (EYPT) closed at $0.31 on Nov 13, 2026; its Tenet Score is 44 of 100 against 409 Healthcare peers.
Key stats
- Previous close
- $0.31
- Nov 13, 2026
- Market cap
- $34.8M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Dividend yield
- 0.00%
- reinvests all
- 52-week range
- 0.31 – 19.11
- low → high
- Tenet Score
- 44/100
- Weak · 409 Healthcare peers
Industry: Drugs · see every company filed here →
EyePoint Inc. scores 44/100. Weak. Strongest on value, quality is the soft spot versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ~ Reversal Evidence
Pays no dividend. Every dollar of profit is reinvested into the business.
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release mi…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Cerus CorpCERS | 33 | $400.9M |
| Editas Medicine, Inc.EDIT | 27 | $334.9M |
| Altimmune IncALT | 54 | $320.1M |
| Elicio Therapeutics, Inc.ELTX | 46 | $42.5M |
| Hyperion Defi, IncHYPD | 56 | $40.0M |
| FORUM MARKETS IncFRMM | 62 | $36.5M |
| GridAI Technologies Corp.GRDX | 31 | $26.7M |
| Lite Strategy, Inc.LITS | 57 | $25.3M |
| First Trust FTSE EPRA/NAREIT Developed Markets Real Estate Index FundFFR | 15 | $24.9M |
| Cara Therapeutics, Inc.TVRD | 49 | $15.8M |
Common questions
What sector and industry is EyePoint in?
EyePoint is in the Healthcare sector and the Drugs industry.
What is EyePoint's Tenet Score?
EyePoint's Tenet Score is 44 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




